🇺🇸 FDA
Patent

US 10945996

Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis

granted A61KA61K31/428A61K45/06

Quick answer

US patent 10945996 (Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis) held by THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/428, A61K45/06, A61K9/0056, A61K9/14